RETN and Neonatal sepsis: Recent studies have demonstrated that novel biomarkers, such as resistin, haptoglobin, and sTREM-1, could be applied for clinical prognostic identification of neonatal sepsis, but their expensive and time-consuming disadvantage hinders widespread implication in neonatal sepsis [6,7].